Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study

BACKGROUND: There have been scarce data on the distribution of clozapine concentrations in comparison with the recommended range (350–600 ng/ml) or their relationship with side effects among patients with treatment-resistant schizophrenia. Furthermore, no studies have assessed the association betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Nobuyuki, Kitagawa, Kohei, So, Ryuhei, Misawa, Fuminari, Kodama, Masafumi, Takeuchi, Hiroyoshi, Bies, Robert, Straubinger, Thomas, Banker, Christopher, Mizuno, Yuya, Mimura, Masaru, Uchida, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138292/
https://www.ncbi.nlm.nih.gov/pubmed/34046160
http://dx.doi.org/10.1177/20451253211016189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138292/
https://www.ncbi.nlm.nih.gov/pubmed/34046160
http://dx.doi.org/10.1177/20451253211016189

Ejemplares similares